Provides a model-informed precision dosing platform that uses patient-specific pharmacological data to optimize drug regimens in real time, reducing adverse drug events and improving treatment efficacy. The platform integrates with electronic health records and supports clinical decision-making for providers and biopharma companies, enabling safer, cost-effective care across therapeutic areas like infectious diseases and bone marrow transplantation.
Funding
$12.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
+4Founders
Product
Problem
Current drug dosing methods often rely on population averages, failing to account for individual patient variability in pharmacokinetics and pharmacodynamics. This can lead to sub-optimal drug exposure, resulting in adverse drug events, reduced efficacy, and increased healthcare costs. The lack of real-time, patient-specific data integration further complicates the optimization of drug regimens.
Solution
InsightRX offers a model-informed precision dosing (MIPD) platform that leverages patient-specific pharmacological data to optimize drug regimens in real time. The platform integrates with electronic health records (EHRs) to provide clinical decision support for healthcare providers and biopharmaceutical companies. By using Bayesian modeling and real-time clinical analytics, InsightRX enables individualized treatment strategies that maximize drug efficacy while minimizing adverse events. The platform supports various therapeutic areas, including infectious diseases and bone marrow transplantation, and facilitates continuous learning through population-level data analysis. InsightRX's solutions aim to transform hospital pharmacies from cost centers to partners in precision dosing, improving patient safety and driving clinical innovation.
Target Audience
The primary target audience includes healthcare providers, such as physicians and pharmacists, seeking to optimize drug dosing for individual patients, as well as biopharmaceutical companies aiming to improve drug efficacy and safety in clinical trials.
Features
- Bayesian forecasting engine that uses patient-specific data to predict drug response
- Integration with EHR systems for seamless data exchange and workflow optimization
- Clinical decision support tools that provide dosing recommendations and alerts
- Real-time clinical analytics dashboards for monitoring medication-related patient safety and efficacy
- Drug modules tailored to specific therapeutic areas, such as infectious disease and bone marrow transplant
- Continuous learning capabilities that leverage real-world data to improve dosing accuracy
- Support for precision dosing in clinical trials, enabling biomarker-guided dose optimization
- Companion applications to maximize the therapeutic potential of new drugs and biologics